Sickness Absence Management: A Global Employer’s Guide

A global employer’s guide to quantifying sickness absence costs, improving return-to-work outcomes and building a medically informed sickness absence management program.

For global employers, managing sickness absence consistently can be difficult to achieve. Legal requirements, medical certification, privacy rules, occupational health provision and return-to-work practices differ across countries. Fragmented local processes can make it harder to understand the total business impact of sickness absence, support employees consistently and compare outcomes across markets.

A medically informed sickness absence management approach connects absence data and HR processes with proportionate occupational health guidance, practical return-to-work planning, recurrence prevention and outcome measurement. It helps employers move beyond recording days lost to understanding where workforce capacity is being lost, why employees may be absent and how effectively it is being restored.

The Business Cost of Sickness Absence

The scale of sickness absence can be significant. Using illustrative UK sickness absence and US employment-cost assumptions, a 50,000-person workforce could experience approximately USD 79.9 million in direct employment cost from sickness absence annually. This excludes overtime, replacement labour, productivity loss, management time, recurrence, presenteeism and delayed return-to-work costs.

These figures are not intended as a universal benchmark. The white paper explains how employers can localize the model using their own workforce, payroll, benefits, absence and replacement-cost data.

What's Inside the Paper

• The business impact of sickness absence: Understand why recorded absence days reveal only part of the cost and how workforce size, role criticality and geographical spread affect business exposure.
• A practical sickness absence cost model: Calculate direct employment costs and examine the additional impact of coverage, productivity loss, management time, recurrence and delayed return to work.
• The Sickness Absence Management Value Chain: Apply a seven-stage framework to Identify, Quantify, Triage, Guide, Return, Prevent and Measure Value.
• Occupational Health referral and guidance: Identify when specialist input may be appropriate and translate relevant health information into privacy-safe, work-relevant guidance on functional capacity, restrictions, adjustments and return to work.
• Global governance and local adaptation: Establish consistent principles for occupational health referrals, clinical quality, medical confidentiality, provider management and outcome reporting while respecting local legal and medical requirements.
• Sickness Absence Management program value and ROI: Build a credible investment case, model potential returns, define meaningful measures and connect sickness absence management to sustained return to work, reduced recurrence and avoided costs.
• A practical path to implementation: Use the six-month roadmap and organizational self-assessment to identify current maturity, priority markets, occupational health referral gaps, provider variation and the next practical steps.

A framework for restoring workforce capacity

The Sickness Absence Management Value Chain provides a structured approach for moving from fragmented and reactive administration to a medically informed, measurable and globally adaptable model:

The objective is not simply to reduce recorded sickness absence days. Effective sickness absence management should support earlier and more appropriate action, enable safe and sustainable return to work, reduce avoidable recurrence and restore workforce capacity.

Who Should Read This White Paper? 

This white paper is designed for: